Dynamic tracing of immune cells in an orthotopic gastric carcinoma mouse model using near-infrared fluorescence live imaging

Experimental and Therapeutic Medicine

Volumn 4, Issue 2, 2012, Pages 221-225

  Du, Xiaohui ^a,b   Wang, Xiangyu ^a   Ning, Ning ^a,b   Xia, Shaoyou ^a,b   Liu, Juchao ^a   Liang, Wentao ^a   Sun, Huiwei ^a   Xu, Yingxin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Chinese PLA General Hospital Hainan Branch   (China)

Author keywords

Antitumor effect; Cytokine induced killer cells; Cytotoxic t lymphocytes; Gastric carcinoma orthotopic model; Near infrared fluorescence live imaging

Indexed keywords

FIBRINOGEN; FLUORESCENT DYE; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER LOCALIZATION; CANCER MODEL; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOCOMPETENT CELL; ISOTOPE TRACING; MOUSE; NONHUMAN; NORMAL HUMAN; NUDE MOUSE; STOMACH CARCINOMA;

EID: 84862648285     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.579     Document Type: Article

References (25)

1. Rosenberg SA, Yang JC and Restifo NP: Cancer immunotherapy: moving beyond current vaccines. Nat Med 10: 909-915, 2004.
2. Dudley ME, Wunderlich JR, Robbins PF, et al: Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298: 850-854, 2002.
3. Dudley ME, Wunderlich JR, Yang JC, et al: Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 23: 2346-2357, 2005.
4. Frangioni JV: In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7: 626-634, 2003.
5. He X, Gao J, Gambhir SS and Cheng Z: Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med 16: 574-583, 2010.
6. Kalchenko V, Shivtiel S, Malina V, et al: Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing. J Biomed Opt 11: 050507, 2006.
7. Granot D, Addadi Y, Kalchenko V, Harmelin A, Kunz-Schughart LA and Neeman M: In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. Cancer Res 67: 9180-9189, 2007.
8. Hemmrich K, Meersch M, von Heimburg D and Pallua N: Applicability of the dyes CFSE, CM-DiI and PKH26 for tracking of human preadipocytes to evaluate adipose tissue engineering. Cells Tissues Organs 184: 117-127, 2006.
9. Kikkawa YS and Pawlowski KS: Cochlear neuronal tracing for frequency mapping with DiI, NeuroVue, and Golgi methods. Acta Otolaryngol Suppl 559: 19-23, 2007.
10. Jiang J, Xu N, Wu C, et al: Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res 26: 2237-2242, 2006.
11. Kim HM, Kang JS, Lim J, et al: Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model. Arch Pharm Res 32: 781-787, 2009.
12. Toh U, Fujii T, Mishima M, et al: Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer. Gan To Kagaku Ryoho 34: 1931-1933, 2007 (In Japanese).
13. Wongkajornsilp A, Sangsuriyong S, Hongeng S, Waikakul S, Asavamongkolkul A and Huabprasert S: Effective osteosarcoma cytolysis using cytokine-induced killer cells pre-inoculated with tumor RNA-pulsed dendritic cells. J Orthop Res 23: 1460-1466, 2005.
14. Yamagishi H, Ueda Y and Oka T: A case report of immunotherapy on a patient with advanced gastric cancer by adoptive transfer of OK-432-reactive HLA-matched allogeneic lymphocytes. Cancer Immunol Immunother 46: 113-119, 1998.
15. Schmidt-Wolf IG, Lefterova P, Johnston V, Huhn D, Blume KG and Negrin RS: Propagation of large numbers of T cells with natural killer cell markers. Br J Haematol 87: 453-458, 1994.
16. Linn YC and Hui KM: Cytokine-induced NK-like T cells: from bench to bedside. J Biomed Biotechnol 2010: 435745, 2010.
17. Linn YC, Lau LC and Hui KM: Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts. Br J Haematol 116: 78-86, 2002.
18. Lopez RD, Waller EK, Lu PH and Negrin RS: CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56+ T cells. Cancer Immunol Immunother 49: 629-640, 2001.
19. Mehta BA, Schmidt-Wolf IG, Weissman IL and Negrin RS: Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. Blood 86: 3493-3499, 1995.
20. Koya RC, Mok S, Comin-Anduix B, et al: Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses. Proc Natl Acad Sci USA 107: 14286-14291, 2010.
21. Shu CJ, Radu CG, Shelly SM, et al: Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen. Int Immunol 21: 155-165, 2009.
22. Butler MO, Lee JS, Ansen S, et al: Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell. Clin Cancer Res 13: 1857-1867, 2007.
23. Mackensen A, Meidenbauer N, Vogl S, Laumer M, Berger J and Andreesen R: Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 24: 5060-5069, 2006.
24. Yamaguchi Y, Ohshita A, Hironaka K, et al: Adoptive immunotherapy using autologous lymphocytes sensitized with HLA class I-matched allogeneic tumor cells. Oncol Rep 16: 165-169, 2006.
25. Yee C, Thompson JA, Byrd D, et al: Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA 99: 16168-16173, 2002.